Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects
Metabolic dysfunction-associated fatty liver disease (MASLD) is a rising global health concern. In addition to direct hepatic complications, extra-hepatic complications, including cardiovascular diseases (CVD), type 2 diabetes (T2D), gastroesophageal reflux disease, chronic kidney disease and some m...
Saved in:
| Main Authors: | Jamie Cheung, Bernard Man-Yung Cheung, Kai-Hang Yiu, Hung-Fat Tse, Yap-Hang Chan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1573841/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation
by: Chun‐Ka Wong, et al.
Published: (2025-05-01) -
Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride
by: Yuen-Ting Cheng, et al.
Published: (2025-03-01) -
Cardiovascular risks associated with adjuvant endocrine therapy in women with breast cancer: a population-based cohort study
by: Iokfai Cheang, et al.
Published: (2025-07-01) -
Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction
by: Kento Takeuchi, et al.
Published: (2024-10-01) -
Integrated Care Using the ABCstroke Pathway Improves Cardiovascular Outcomes and Survival in Patients with First-Ever Ischaemic Stroke
by: Christopher T. W. Tsang, et al.
Published: (2025-05-01)